Overview

Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes

Status:
Completed

Trial end date:
2002-12-01

Target enrollment:

Participant gender:

Summary

This trial is conducted in Europe and Oceania. The aim of this trial is to assess the effect on glycemic control of NNC 90-1170 (liraglutide) added to metformin compared to metformin given alone in subjects with type 2 diabetes previously treated with OHAs (oral hypoglycaemic agents).

Phase:

Phase 2

Details

Lead Sponsor:

Novo Nordisk A/S

Treatments:

Glimepiride
Liraglutide
Metformin